Anirban Basu

Anirban Basu

University of Washington

H-index: 54

North America-United States

About Anirban Basu

Anirban Basu, With an exceptional h-index of 54 and a recent h-index of 39 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Health Economics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Acceptance of insurance by psychiatrists and other physicians, 2007–2016

Logical Inconsistencies with Expected Utility Theory May Align Better with Patient Preferences—A Response to Paulden et al.

Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California

Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States: A Cost-Effectiveness Analysis

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework

Use of race in clinical algorithms

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries

Anirban Basu Information

University

Position

___

Citations(all)

17453

Citations(since 2020)

9569

Cited By

11954

hIndex(all)

54

hIndex(since 2020)

39

i10Index(all)

140

i10Index(since 2020)

116

Email

University Profile Page

University of Washington

Google Scholar

View Google Scholar Profile

Anirban Basu Skills & Research Interests

Health Economics

Top articles of Anirban Basu

Title

Journal

Author(s)

Publication Date

Acceptance of insurance by psychiatrists and other physicians, 2007–2016

Psychiatric Services

Andrew D Carlo

Anirban Basu

Jürgen Unützer

Neil Jordan

2024/1/1

Logical Inconsistencies with Expected Utility Theory May Align Better with Patient Preferences—A Response to Paulden et al.

Value in Health

Anirban Basu

2024/3/12

Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California

Donghoon Lee

Anirban Basu

Jerome A. Dugan

Pinar Karaca-Mandic

2024/3/4

Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment

Cancer Epidemiology, Biomarkers & Prevention

Noah Hammarlund

Sarah K Holt

Anirban Basu

Ruth Etzioni

Danté Morehead

...

2024/3/1

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States: A Cost-Effectiveness Analysis

Annals of Internal Medicine

Anirban Basu

Aaron N Winn

Kate M Johnson

Boshen Jiao

Beth Devine

...

2024/2

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework

Value in Health

Boshen Jiao

Josh J Carlson

Louis P Garrison Jr

Anirban Basu

2024/1/6

Use of race in clinical algorithms

Science Advances

Anirban Basu

2023/5/26

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries

Blood Advances

Boshen Jiao

Kate M Johnson

Scott D Ramsey

MA Bender

Beth Devine

...

2023/7/11

Can we predict trial failure among older adult-specific clinical trials using trial-level factors?

Woojung Lee

Anirban Basu

Josh J Carlson

David Veenstra

2023/1/1

A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 1-Data From Wearable Devices

Woojung Lee

Naomi Schwartz

Aasthaa Bansal

Sara Khor

Noah Hammarlund

...

2023/2/1

Understanding differences between what alternate propensity score methods estimate

Journal of Managed Care & Specialty Pharmacy

Anirban Basu

Aig Unuigbe

Cristina Masseria

2023/4

Hospital Performance Under Alternative Readmission Measures Incorporating Observation Stays

Medical care

Amber K Sabbatini

Joshua M Liao

Brad Wright

Anirban Basu

William Kreuter

...

2023/11/1

The price elasticity of Gleevec in patients with Chronic Myeloid Leukemia enrolled in Medicare Part D: Evidence from a regression discontinuity design

arXiv preprint arXiv:2305.06076

Samantha E Clark

Ruth Etzioni

Jerry Radich

Zachary Marcum

Anirban Basu

2023/5/10

Can Value-of-Information Estimates Help Funding Organizations Prioritize which Cancer Studies to Fund?

Scott D Ramsey

Josh J Carlson

David L Veenstra

Anirban Basu

Caroline S Bennette

...

2023/12/20

P8 Bias in, Bias out? Implications of Using Real-World Data with Differentially Measured Outcomes to Generate Prediction Models When Race Is a Predictor

Value in Health

S Khor

PJ Heagerty

A Basu

A Bansal

2023/6/1

Public spending on acute and long‐term care for Alzheimer's disease and related dementias

Alzheimer's & Dementia

Norma B Coe

Lindsay White

Melissa Oney

Anirban Basu

Eric B Larson

2023/1

STUDY PROTOCOL

Katelyn M Sileo

Christine Muhumuza

Samuel Sekamatte

Haruna Lule

Rhoda K Wanyenze

...

2022

Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications

Medical Decision Making

Wei-Jhih Wang

Aasthaa Bansal

Caroline Savage Bennette

Anirban Basu

2023/4

Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis

Value in Health

Stacey Kowal

Carmen D Ng

Robert Schuldt

Daniel Sheinson

Kimberly Jinnett

...

2023/10/1

Racial Disparities in the Ascertainment of Cancer Recurrence in Electronic Health Records

JCO Clinical Cancer Informatics

Sara Khor

Patrick J Heagerty

Anirban Basu

Eric C Haupt

Lindsay Joe L Lyons

...

2023/5

See List of Professors in Anirban Basu University(University of Washington)

Co-Authors

H-index: 116
Joshua A. Salomon

Joshua A. Salomon

Stanford University

H-index: 95
David Feeny

David Feeny

McMaster University

H-index: 90
Karen Kuntz

Karen Kuntz

University of Minnesota-Twin Cities

H-index: 81
David Meltzer

David Meltzer

University of Chicago

H-index: 79
Willard Manning

Willard Manning

University of Chicago

H-index: 78
Murray Krahn

Murray Krahn

University of Toronto

academic-engine